Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06526455Phase 4Not Yet Recruiting

Efficacy and Safety of Vonorasan Versus Esomeprazole in the Treatment of Ulcers After Endoscopic Submucosal Dissection

Role: collaborator

NCT03406832Not ApplicableUnknown

Prevention of Coronary Slow Flow or No-Reflow During EPCI in Patients With Acute STEMI

Role: collaborator

NCT03406819Not ApplicableUnknown

Prevention of Coronary Slow Flow or No-Reflow During PPCI in Patients With Acute STEMI

Role: collaborator

All 3 trials loaded